longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ACOTEC-B

06669

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -32.84, below the reasonable range, cheaper than 99.23% of the time in the past 3 years, and the industry ranks 28/32, the industry Median 9.41.

-32.84xP/E
HK$6.06Stock price
HK$-0.18Earnings per share
-32.84xP/E
Stock priceHK$6.06Earnings per shareHK$-0.18

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
56.54x
Typical range
34.22x–130.36x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.41x
012243648

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.41x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
02526HKDIAGENS-B
-259.10x--HK$36.30B
02252HKMircroPort Medbot-B
-79.03x137.24%HK$21.84B
02675HKEDGE MEDICAL-B
-618.62x--HK$13.37B
02697HKTH MEDICAL-B
-103.11x--HK$11.14B
09996HKPEIJIA-B
-20.10x104.51%HK$3.26B
09877HKJENSCARE-B
-17.17x--HK$2.97B
06669HKACOTEC-B
-32.84x12.37%HK$1.90B
02160HKMP CARDIOFLOW-B
-11.13x94.94%HK$1.63B
06922HKCRYOFOCUS-B
-18.38x--HK$622.77M
02500HKVENUS MEDTECH-B
-0.94x100.95%HK$502.75M
02185HKBIOHEART-B
-4.58x--HK$397.99M
02216HKBRONCUS-B
-2.40x--HK$342.60M
02297HKRAINMED-B
-3.04x--HK$234.03M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.